<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib33">
 <label>33</label>
 <element-citation publication-type="journal" id="sref33">
  <person-group person-group-type="author">
   <name>
    <surname>Boussemart</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Malka-Mahieu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Girault</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Allard</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hemmingsson</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Tomasic</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Thomas</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Basmadjian</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ribeiro</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Thuaud</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Mateus</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Routier</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Kamsu-Kom</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Agoussi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Eggermont</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>DÃ©saubry</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Robert</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Vagner</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies</article-title>
  <source>Nature</source>
  <volume>513</volume>
  <year>2014</year>
  <fpage>105</fpage>
  <lpage>109</lpage>
 </element-citation>
</ref>
